Clinical Trial Update: A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial update reports results for maintenance therapy with rucaparib and nivolumab in ovarian cancer patients who responded to frontline platinum chemo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• OPDIVO (nivolumab)
• RUBRACA (RUCAPARIB)

Snippet

Sponsor: pharmaand GmbH | Conditions: Epithelial Ovarian Cancer, Primary Peritoneal | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-06-24